Company Profile>
Group leader>
Development History>
Drug products>
APIs and Intermediates>
Veterinary drugs>
R&D system>
Intellectual property system>
Production quality system>
News Information>
Media attention>
Stock information>
Company Announcement>
Interactive communication>
Talent concept>
Company Activity>
Social recruitment>
OA system>
Enterprise mailbox>
Electronic collaboration>
合作共赢 开创未来|博瑞医药参展行程圆满收官!
2023-10-31
博瑞医药博立宁®首张处方开出,为乳腺癌化疗提供新选择
2023-09-04
董事长袁建栋应邀参加2023科创板开市四周年论坛
2023-07-25
博瑞医药入选2023苏州民营企业创新100强
不忘初心,砥砺前行|博瑞医药CPHI2023泰国展圆满收官
2023-07-18
重磅回归,焕新而来|博瑞医药2023上海CPHI展会之行圆满落幕
2023-06-21
山海相逢,不负期待 |博瑞医药第88届API China展会盛况再现
2023-04-17
博瑞医药上榜中国新经济企业500强
2023-04-01
博瑞医药支持Cidara Therapeutics抗菌药Rezafungin(雷扎芬净)获FDA批准
2023-03-24